Nuance Communications, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Nuance Communications, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4653
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Nuance Communications, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Nuance Communications, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Nuance Communications, Inc. (Nuance) is a provider of voice and language solutions for businesses and consumers. It offers customers high accuracy in automated speech recognition, capabilities for natural language understanding, dialog and information management, biometric speaker authentication, text-to-speech, optical character recognition capabilities, and domain knowledge. Nuance also provides professional services and implementation support. The company’s solutions are used in healthcare, mobile, consumer, enterprise customer service, and imaging markets. Nuance markets its solutions and technologies through a network of sales team, e-commerce website and also through a global network of resellers, including system integrators, independent software vendors, value-added resellers, distributors, hardware vendors, and telecommunications carriers. The company has business presence in the US, Europe and Asia and is headquartered in Burlington, Massachusetts, the US.

Scope

- Detailed information on Nuance Communications, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Nuance Communications, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Nuance Communications, Inc. including a breakdown and examination of key business segments
- Intelligence on Nuance Communications, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Nuance Communications, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Nuance Communications, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Nuance Communications, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Nuance Communications, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Nuance Communications, Inc.: Company Overview 9
Nuance Communications, Inc.: Overview and Key Facts 9
Nuance Communications, Inc.: Overview 9
Nuance Communications, Inc.: Key Facts 9
Nuance Communications, Inc.: Key Employees 11
Nuance Communications, Inc.: Key Employee Biographies 12
Nuance Communications, Inc.: Major Products and Services 15
Nuance Communications, Inc.: Company History 16
Nuance Communications, Inc.: Management Statement 21
Nuance Communications, Inc.: Locations and Subsidiaries 26
Nuance Communications, Inc.: Key Competitors 27
Nuance Communications, Inc.: Company Analysis 28
Nuance Communications, Inc.: Business Description 28
Nuance Communications, Inc.: SWOT Analysis 30
Nuance Communications, Inc.: SWOT Overview 30
Nuance Communications, Inc.: Strengths 30
Nuance Communications, Inc.: Weaknesses 31
Nuance Communications, Inc.: Opportunities 31
Nuance Communications, Inc.: Threats 32
Nuance Communications, Inc.: Corporate Financial Deals Activity 34
Nuance Communications, Inc.: Financial Deals Overview 34
Nuance Communications, Inc.: Targets and Partners 36
Nuance Communications, Inc.: Top Deals 2014 – 2018YTD* 37
Nuance Communications, Inc.: Mergers and Acquisitions 38
Nuance Communications, Inc.: Capital Raising 39
Nuance Communications, Inc.: Recent Developments 40
Nuance Communications, Inc.: News and Events Summary 40
Nuance Communications, Inc.: Business Expansion 43
Nuance Communications, Inc.: Contracts 43
Nuance Communications, Inc.: Corporate Governance 45
Nuance Communications, Inc.: Financial Deals 46
Nuance Communications, Inc.: Research & Development 46
Nuance Communications, Inc.: Strategy and Operations 46
Appendix 48
Contact Us 48
Methodology 48
About MarketLine 49

List of Tables
Table 1: Nuance Communications, Inc.: Key Facts
Table 2: Nuance Communications, Inc.: Key Employees
Table 3: Nuance Communications, Inc.: Locations and Subsidiaries
Table 4: Nuance Communications, Inc.: Key Competitors
Table 5: Nuance Communications, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Nuance Communications, Inc.: M&A Activity by Geography (TTM*)
Table 7: Nuance Communications, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Nuance Communications, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Nuance Communications, Inc.: Targets and Partners
Table 10: Nuance Communications, Inc.: Top Deals 2014 - 2018YTD*
Table 11: Nuance Communications, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Nuance Communications, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Nuance Communications, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Nuance Communications, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Nuance Communications, Inc.: News and Events Summary
Table 16: Nuance Communications, Inc.: Business Expansion
Table 17: Nuance Communications, Inc.: Contracts
Table 18: Nuance Communications, Inc.: Corporate Governance
Table 19: Nuance Communications, Inc.: Financial Deals
Table 20: Nuance Communications, Inc.: Research & Development
Table 21: Nuance Communications, Inc.: Strategy and Operations

List of Figures
Figure 1: Nuance Communications, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Nuance Communications, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Nuance Communications, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Nuance Communications, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Nuance Communications, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Nuance Communications, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Nuance Communications, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Nuance Communications, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Nuance Communications, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CohBar Inc (CWBR):製薬・医療:M&Aディール及び事業提携情報
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • Airports of Thailand Plc (AOT):企業の財務・戦略的SWOT分析
    Airports of Thailand Plc (AOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sonic Healthcare Limited:企業のM&A・事業提携・投資動向
    Sonic Healthcare Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sonic Healthcare Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Orig3N Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orig3N Inc (Orig3N), a biotechnology company that focuses on the research, development and treatment of genetically inherited diseases. The company offers DNA test kits which include SUPERHERO for analyzing strength, intelligence and speed; FITNESS that provides reports and analysis on vario …
  • Ability Pharmaceuticals SL-製薬・医療分野:企業M&A・提携分析
    Summary Ability Pharmaceuticals SL (Ability Pharma), formerly known as AB Therapeutics S.L., is a clinical stage biopharmaceutical company that focuses on drug discovery and development. It develops human therapeutics to treat lung, pancreatic and gynecological cancers. The company’s lead pipeline p …
  • BioMarin Pharmaceutical Inc (BMRN):企業の財務・戦略的SWOT分析
    BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • AutoZone Inc (AZO):企業の財務・戦略的SWOT分析
    AutoZone Inc (AZO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • POET Technologies Inc (PTK):電力:M&Aディール及び事業提携情報
    Summary POET Technologies Inc (POET), a subsidiary of Pinetree Capital Ltd, is a technology company that develops integrated circuit platforms. The company provides products such as narrow linewidth laser, broadband light sources, data communications products and active and passive components, among …
  • Clinipace Worldwide Inc-医療機器分野:企業M&A・提携分析
    Summary Clinipace Worldwide Inc (Clinipace) is a contract research company that offers drug and medical devices development services. The company’s services include biostatistics, clinical monitory, chemistry, manufacturing and control, data management, GCP training, global study feasibility, medica …
  • EKF Diagnostics Holdings Plc (EKF)-医療機器分野:企業M&A・提携分析
    Summary EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company which designs, develops, manufactures, and commercializes chemical reagents, and analyzers for the measurement of glucose, lactate, hematocrit, hemoglobin, and glycated hemoglobin. The company’s product portfolio comp …
  • NIKE Inc:戦略・SWOT・企業財務分析
    NIKE Inc - Strategy, SWOT and Corporate Finance Report Summary NIKE Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Baron Oil Plc (BOIL):企業の財務・戦略的SWOT分析
    Summary Baron Oil Plc (Baron Oil), formerly Gold Oil PLC is an oil and gas exploration and production company. The company identifies and develops crude oil and natural gas interests in Latin America including Peru and Colombia. It also holds working interests of Nancy Burdine Maxine oil field, oil …
  • General Electric Company:戦略・SWOT・企業財務分析
    General Electric Company - Strategy, SWOT and Corporate Finance Report Summary General Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Aeterna Zentaris Inc (AEZS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aeterna Zentaris Inc (Aeterna Zentaris) is a specialty biopharmaceutical company that focuses on the development and commercialization of novel pharmaceutical therapies for the treatment of endocrine disorders. The company’s lead product, macimorelin, a ghrelin receptor agonist and orally-ac …
  • FDM Group (Holdings) plc (FDM):企業の財務・戦略的SWOT分析
    FDM Group (Holdings) plc (FDM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • IMPACT Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary IMPACT Therapeutics Inc (IMPACT) is a developer of therapeutics to treat cancer and other life-threatening diseases. The company provides products such as microtubule inhibitors, PARP-1 inhibitors, and Hedgehog pathway inhibitors for oncology. Its PARP-1 inhibitor is an oral bioavailability; …
  • Intercept Pharmaceuticals Inc (ICPT)-製薬・医療分野:企業M&A・提携分析
    Summary Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops and commercializes treatments for non-viral, progressive liver diseases. It develops products using its proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid ( …
  • The Bank of East Asia, Limited:企業の戦略・SWOT・財務情報
    The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Apetit Oyj:企業の戦略・SWOT・財務情報
    Apetit Oyj - Strategy, SWOT and Corporate Finance Report Summary Apetit Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • XERIS Pharmaceuticals Inc (XERS):製薬・医療:M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆